| 产品名称: | U2OS#18-RAD51B-8 |
|---|---|
| 商品货号: | TS260413 |
| <strong>Cell line </strong>: | U2OS#18-RAD51B-8 |
| DSMZ no. : | TS260413 |
| Species : | human |
| Cell type : | osteosarcoma |
| Origin : | Genetic modification of U2OS#18 (DSMZ ACC 832, a reporter cell line for studying sister chromatid recombination, SCR) with a genetic disruption of RAD51B by frameshifting mutations in exon 3 (targeted by CRISPR-CAS9; puromycin resistant and expressing GFP). The wild-type allele is no longer present. A sister cell line with the retrovirally reconstituted RAD51B gene is available as ACC 838 |
| Reference(s) : | 18169, 18186 |
| Biosafety level : | 1, GMO-S1 |
| Risk assessment : | genetically modified organism, according to German and European legislation allocated into group S1 |
| Permissions and restrictions : | A, D |
| <strong> </strong>: | DSMZ Scientific Data: |
| Morphology: | epithelioid cells growing adherently as monolayer; image; image |
| Medium : | 90% Dulbecco´s MEM + 10% h.i. FBS + (additionally) 2 mM L-glutamine; (to verify puromycin resistance, 1 µg/ml should be added) |
| Subculture : | seed out at 1 x 106 cells/175 cm2; split confluent culture once a week 1:8 to 1:10 using trypsin/EDTA |
| Incubation : | at 37 °C with 10% CO2 |
| Doubling time : | ca. 50 hours |
| Harvest : | cell harvest of 8-10 x 106 cells/175 cm2 flask |
| Storage : | frozen with 70% medium, 20% FBS, 10% DMSO |
| Mycoplasma : | negative in PCR assay |
| Immunology : | to inquire about expression of EpCAM and intermediate filaments, contact hilmar.quentmeier@dsmz.de. |
| Fingerprint : | fluorescent nonaplex PCR revealed an authentic STR DNA profile as cell line U-2-OS (DSMZ ACC 785) |
| Molec. Genetics : | frameshift mutation in exon 3 of RAD51B was verified by sequence analysis |
| Viruses : | PCR: EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-I/II -, MLV - |
| 产品名称: | U2OS#18-RAD51B-8 |
|---|---|
| 商品货号: | TS260413 |
| <strong>Cell line </strong>: | U2OS#18-RAD51B-8 |
| DSMZ no. : | TS260413 |
| Species : | human |
| Cell type : | osteosarcoma |
| Origin : | Genetic modification of U2OS#18 (DSMZ ACC 832, a reporter cell line for studying sister chromatid recombination, SCR) with a genetic disruption of RAD51B by frameshifting mutations in exon 3 (targeted by CRISPR-CAS9; puromycin resistant and expressing GFP). The wild-type allele is no longer present. A sister cell line with the retrovirally reconstituted RAD51B gene is available as ACC 838 |
| Reference(s) : | 18169, 18186 |
| Biosafety level : | 1, GMO-S1 |
| Risk assessment : | genetically modified organism, according to German and European legislation allocated into group S1 |
| Permissions and restrictions : | A, D |
| <strong> </strong>: | DSMZ Scientific Data: |
| Morphology: | epithelioid cells growing adherently as monolayer; image; image |
| Medium : | 90% Dulbecco´s MEM + 10% h.i. FBS + (additionally) 2 mM L-glutamine; (to verify puromycin resistance, 1 µg/ml should be added) |
| Subculture : | seed out at 1 x 106 cells/175 cm2; split confluent culture once a week 1:8 to 1:10 using trypsin/EDTA |
| Incubation : | at 37 °C with 10% CO2 |
| Doubling time : | ca. 50 hours |
| Harvest : | cell harvest of 8-10 x 106 cells/175 cm2 flask |
| Storage : | frozen with 70% medium, 20% FBS, 10% DMSO |
| Mycoplasma : | negative in PCR assay |
| Immunology : | to inquire about expression of EpCAM and intermediate filaments, contact hilmar.quentmeier@dsmz.de. |
| Fingerprint : | fluorescent nonaplex PCR revealed an authentic STR DNA profile as cell line U-2-OS (DSMZ ACC 785) |
| Molec. Genetics : | frameshift mutation in exon 3 of RAD51B was verified by sequence analysis |
| Viruses : | PCR: EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-I/II -, MLV - |